Display options
Share it on
Full text links
Springer

Eur J Clin Pharmacol. 1988;34(4):343-52. doi: 10.1007/BF00542434.

Influence of naloxone on the postoperative analgesic and respiratory effects of buprenorphine.

European journal of clinical pharmacology

K A Lehmann, U Reichling, R Wirtz

Affiliations

  1. Institut für Anaesthesiologie, Universität zu Köln, FRG.

PMID: 3402520 DOI: 10.1007/BF00542434

Abstract

Eighty patients recovering from major operations were investigated to evaluate the influence of naloxone on the analgesic and respiratory depressant properties of buprenorphine. They were randomly assigned to two groups to self-administer either buprenorphine (Group B) or a mixture of buprenorphine and naloxone (fraction 60%; Group BN) in the early postoperative period by means of the On-Demand Analgesia Computer (ODAC). The duration of patient-controlled analgesia (PCA) was 21.0 h (B) or 23.5 h (BN), during which 12.2 (B) and 18.2 (BN) demands per patient were recorded, representing significantly different consumption of buprenorphine 0.80 (B) and 1.07 (BN) microgram.kg-1.h-1. Retrospective pain scores were significantly better in Group B, and respiratory rate was significantly higher in Group BN. The analgesia was judged superior by 81% (B) and 88% (BN) of the patients compared to conventional postoperative pain treatment. The minimum effective buprenorphine concentration (MEC) varied greatly in both groups with no significant differences between them (median 0.4 ng.ml-1, range 0.1-8.6 ng.ml-1); intra-individual variability was lower (67.9% B, and 58.2% BN) than inter-individual variability (107.3% B and 84.0% BN). Accumulation in plasma and acute tolerance did not occur. Thus, admixture of 60% naloxone decreased both the analgesic and respiratory depressant effects of buprenorphine which were generally independent of plasma concentrations. The analgesia achieved with the buprenorphine/naloxone mixture under patient-controlled conditions was comparable to that of other narcotic analgesics. Accordingly, this drug combination may be expected to give clinically adequate analgesia without notable impairement of spontaneous respiration, whilst withdrawal symptoms would probably arise in drug addicts abusing other opiates.

Cited by

References

  1. Anesthesiology. 1984 Jul;61(1):19-26 - PubMed
  2. Clin Pharmacokinet. 1982 Mar-Apr;7(2):164-75 - PubMed
  3. Acta Anaesthesiol Belg. 1985 Mar;36(1):33-40 - PubMed
  4. Anaesthesist. 1986 Apr;35(4):219-25 - PubMed
  5. Br J Anaesth. 1982 Mar;54(3):279-84 - PubMed
  6. Br J Anaesth. 1986 May;58(5):508-11 - PubMed
  7. Clin Pharmacol Ther. 1980 Nov;28(5):667-72 - PubMed
  8. Anaesthesia. 1985 Jun;40(6):583-6 - PubMed
  9. Eur J Clin Pharmacol. 1986;31(3):267-76 - PubMed
  10. Anaesthesist. 1985 Oct;34(10):494-501 - PubMed
  11. Br Med J. 1979 Oct 13;2(6195):895-7 - PubMed
  12. Anesthesiology. 1986 Mar;64(3):322-7 - PubMed
  13. Anaesthesist. 1982 Dec;31(12):655-9 - PubMed
  14. Arzneimittelforschung. 1984;34(9A):1108-14 - PubMed
  15. Anesthesiology. 1982 Dec;57(6):458-67 - PubMed
  16. Br J Anaesth. 1985 Oct;57(10):1045-6 - PubMed
  17. Anaesthesist. 1988 Feb;37(2):65-70 - PubMed
  18. Langenbecks Arch Chir. 1985;367(1):27-40 - PubMed
  19. Eur J Clin Pharmacol. 1980 Oct;18(4):339-45 - PubMed
  20. Br J Anaesth. 1983 Jan;55(1):21-5 - PubMed
  21. Acta Anaesthesiol Belg. 1980;31 Suppl:233-7 - PubMed
  22. Br J Clin Pharmacol. 1981 Aug;12(2):117-22 - PubMed
  23. Acta Anaesthesiol Belg. 1986;37(4):247-57 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources